Full Text
The Full Text of this article is available as a PDF (58.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Campieri M., Gionchetti P. Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative? Gastroenterology. 1999 May;116(5):1246–1249. doi: 10.1016/s0016-5085(99)70029-6. [DOI] [PubMed] [Google Scholar]
- Dugas B., Mercenier A., Lenoir-Wijnkoop I., Arnaud C., Dugas N., Postaire E. Immunity and probiotics. Immunol Today. 1999 Sep;20(9):387–390. doi: 10.1016/s0167-5699(99)01448-6. [DOI] [PubMed] [Google Scholar]
- Kruis W., Schütz E., Fric P., Fixa B., Judmaier G., Stolte M. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther. 1997 Oct;11(5):853–858. doi: 10.1046/j.1365-2036.1997.00225.x. [DOI] [PubMed] [Google Scholar]
- Madsen K. L., Doyle J. S., Jewell L. D., Tavernini M. M., Fedorak R. N. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology. 1999 May;116(5):1107–1114. doi: 10.1016/s0016-5085(99)70013-2. [DOI] [PubMed] [Google Scholar]
- Rembacken B. J., Snelling A. M., Hawkey P. M., Chalmers D. M., Axon A. T. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet. 1999 Aug 21;354(9179):635–639. doi: 10.1016/s0140-6736(98)06343-0. [DOI] [PubMed] [Google Scholar]
- Shanahan F. Nutrient tasting and signaling mechanisms in the gut V. Mechanisms of immunologic sensation of intestinal contents. Am J Physiol Gastrointest Liver Physiol. 2000 Feb;278(2):G191–G196. doi: 10.1152/ajpgi.2000.278.2.G191. [DOI] [PubMed] [Google Scholar]
- Shanahan F. Probiotics and inflammatory bowel disease: is there a scientific rationale? Inflamm Bowel Dis. 2000 May;6(2):107–115. doi: 10.1097/00054725-200005000-00007. [DOI] [PubMed] [Google Scholar]